Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients
Among the potential hazards of HDM immunotherapy (AIT) with HDM allergenic extracts is the possible initiation of de novosensitizations caused by a lack of complementarity between a given HDM vaccine's content and a patient's molecular sensitization profile. To investigate whether immunoth...
Saved in:
Main Authors: | Marita Nittner-Marszalska (Author), Agnieszka Kopeć (Author), Aleksandra Foks-Ciekalska (Author), Aleksandra Lata (Author), Agnieszka Bogacz- Piaseczyńska (Author), Marta Rosiek-Biegus (Author), Magdalena Zajac (Author), Andrzej Bożek (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Responders and nonresponders to pharmacotherapy and allergen immunotherapy
by: Marek Jakalski, et al.
Published: (2019) -
Prolonged effect of allergen sublingual immunotherapy to grass pollen
by: Andrzej Bozek, et al.
Published: (2018) -
Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
by: Andrzej Bozek, et al.
Published: (2022) -
Decorating and loading ghosts with allergens for allergen immunotherapy
by: Songwe Fanuel, et al.
Published: (2017) -
New modalities of allergen immunotherapy
by: Manish Ramesh, et al.
Published: (2018)